Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0000950170-24-013376
Filing Date
2024-02-09
Accepted
2024-02-09 17:14:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 evoke_424b4_feb_8_2024.htm 424B4 838564
2 GRAPHIC img11205409_0.jpg GRAPHIC 7463
3 GRAPHIC img11205409_1.jpg GRAPHIC 7463
  Complete submission text file 0000950170-24-013376.txt   860420
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-275443 | Film No.: 24616144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)